CHEMED Aktie

>CHEMED Aktienkurs

320 EUR -2.4% (TradegateBSX)

Ask: 332 EUR / 30 Stück

Bid: 328 EUR / 30 Stück

Tagesumsatz: 8 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

CHEMED Aktie über LYNX handeln

Intraday

1 Jahr

>CHEMED Performance

1 Woche: 0%

1 Monat: -12,3%

3 Monate: -11,6%

6 Monate: -15,6%

1 Jahr: -40,7%

laufendes Jahr: -13,5%

>CHEMED Aktie

Name:

CHEMED CORP. DL 1

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US16359R1032 / A0CBF4

Symbol/ Ticker:

CXM (Frankfurt) / CHE (NYSE)

Kürzel:

FRA:CXM, ETR:CXM, CXM:GR, NYSE:CHE

Index:

Webseite:

http://www.chemed.com

Profil:

Chemed Corporation operates as a diversified services company through its two primary segments: VITAS Healthcare and Roto-Rooter. VITAS provides hospice and palliative care services to patients across the United States via a comprehensive network of ..
>Volltext..

Marktkapitalisierung:

4502.5 Mio. EUR

Unternehmenswert:

4570.79 Mio. EUR

Umsatz:

2191.76 Mio. EUR

EBITDA:

349.39 Mio. EUR

Nettogewinn:

229.78 Mio. EUR

Gewinn je Aktie:

15.99 EUR

Schulden:

134.07 Mio. EUR

Liquide Mittel:

64.55 Mio. EUR

Operativer Cashflow:

336.37 Mio. EUR

Bargeldquote:

0.26

Umsatzwachstum:

-8.28%

Gewinnwachstum:

-22.59%

Dividende je Aktie:

1.97 EUR

Dividendenrendite:

0.62%

Dividendenschätzung:

0.66%

Div. Historie:

23.02.26 - 0.50808007€
17.11.25 - 0.51738€

>weitere anzeigen...

Insiderhandel:

1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 1.360.415 USD.

Suchwörter:

CHEMED

Letzte Datenerhebung:

05.04.26

>CHEMED Kennzahlen

Aktien/ Unternehmen:

Aktien: 13.77 Mio. St.

Frei handelbar: 98.16%

Leerverk. Aktien: 3.13%

Rückkaufquote: 7.78%

Mitarbeiter: 15811

Umsatz/Mitarb.: 0.14 Mio. EUR

Analysten:

Analystenrating: Neutral

Kursziel: 14.51%

Bewertung:

KGV: 20.97

KGV lG: 15.85

KUV: 2.03

KBV: 5.39

PEG-Ratio: -

EV/EBITDA: 13.08

Rentabilität:

Bruttomarge: 29.86%

Gewinnmarge: 10.48%

Operative Marge: 13.38%

Managementeffizenz:

Gesamtkaprendite: 15.57%

Eigenkaprendite: 25.28%

>CHEMED Peer Group

Gesundheit

>CHEMED Chart & Kurs - NYSE

>CHEMED News

01.04.26 - 18:03	Chemed To Report First Quarter 2026 Earnings April 23, Related Conference Call To Be Held On April 24 (GlobeNewswire EN)
	Q1 2026 Chemed Earnings Call to be held on April 24, 2026....

30.03.26 - 23:01	Insiderhandel: president and CEO verkauft Aktien von Chemed im Wert von 554055 USD (Insiderkauf)
	Mcnamara, Kevin J. - Vorstand - Tag der Transaktion: 2026-03-27...

19.03.26 - 16:18	Chemed-Strategie: VITAS auf Wachstumskurs, Roto-Rooter unter Druck (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

13.03.26 - 19:01	Insiderhandel: president and CEO verkauft Aktien von Chemed im Wert von 806360 USD (Insiderkauf)
	Mcnamara, Kevin J. - Vorstand - Tag der Transaktion: 2026-03-12...

12.03.26 - 17:03	Chemed Corporation to Present at the Oppenheimer 36th Annual Healthcare Conference (GlobeNewswire EN)
	CINCINNATI, March 12, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 36th Annual Healthcare Conference on Thursday, March 19, 2026, at approximately 9:20 a.m. (ET)....

27.02.26 - 20:31	CHE Stock Falls Post Q4 Earnings & Revenue Miss, Margins Crash (Zacks)
	Chemed slips 15% as Q4 earnings and revenue missed estimates, margins contracted, and the 2026 EPS outlook fell short of consensus....

26.02.26 - 21:12	Chemed forecasts 5.5%–6.5% VITAS revenue growth and signals 55% of 2026 earnings to be back-half weighted amid transition initiatives (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

26.02.26 - 20:24	Chemed cut to Neutral at BofA after Q4 miss (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

26.02.26 - 19:24	Chemed (CHE) Q4 2025 Earnings Call Transcript (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

25.02.26 - 23:00	Chemed Non-GAAP EPS of $6.42 misses by $0.61, revenue of $639.3M misses by $19.79M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

25.02.26 - 22:18

Chemed Reports Fourth-Quarter 2025 Results (GlobeNewswire EN)

CINCINNATI, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2025, versus the comparable prior-year period....

22.02.26 - 21:27	XFRA: DIVIDEND/INTEREST INFORMATION - 23.02.2026 - US16359R1032 (XETRA)
	Das Instrument CXM US16359R1032 CHEMED CORP. DL 1 EQUITY wird ex Dividende/Zinsen gehandelt am 23.02.2026 The instrument CXM US16359R1032 CHEMED CORP. DL 1 EQUITY has its ex-dividend/interest day on 23.02.2026...

16.02.26 - 18:48	Chemed Stock Down 15% in a Year as One Fund Builds a $5.56 Million Stake (Fool)
	Chemed Corporation delivers hospice care and essential home services nationwide through its VITAS and Roto-Rooter segments....

13.02.26 - 19:36	Chemed declares $0.60 dividend (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

13.02.26 - 19:24	Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents (GlobeNewswire EN)
	CINCINNATI, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility....

22.01.26 - 17:48	Jefferies lifts Cencora, cuts Acadia and Chemed in healthcare services (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

02.01.26 - 18:03	Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26 (GlobeNewswire EN)
	CINCINNATI, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2025, on Wednesday, February 25, 2026, following the close of trading on the New York Stock Exchange....

18.12.25 - 15:00	Should Investors Hold Chemed Stock in Their Portfolio Now? (Zacks)
	CHE shows growth momentum from VITAS and resilient Roto-Rooter results, but macro headwinds and competition continue to cloud its near-term outlook....

09.12.25 - 19:45	Chemed (CHE) Upgraded to Buy: Here′s What You Should Know (Zacks)
	Chemed (CHE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy)....

04.12.25 - 18:03	Chemed Corporation to Present at the BofA Securities 2025 Virtual Home Care Conference (GlobeNewswire EN)
	CINCINNATI, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2025 Virtual Home Care Conference on Tuesday, December 9, 2025, at 1:20 PM (ET)....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Notwendigkeit ist bei weitem stärker als die Kunst. - Aischylos

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram